TD Cowen Initiates Coverage On Korsana Biosciences with Buy Rating

Benzinga Newsdesk www.benzinga.com Neutral 69.1%

Neg 0% Neu 69.1% Pos 0%

TD Cowen analyst Tyler Van Buren initiates coverage on Korsana Biosciences (NASDAQ:KRSA) with a Buy rating.

Comments

No comments yet. Be the first!